Form 13-F position report

CASI PHARMACEUTICALS HLDGS INC

Reported by Foresite Capital Management VI LLC

Manager portfolio Source filing
CASI CUSIP G1933S101 Manager CIK 0002013341
Latest reported change

Reported 1,329,383 shares, unchanged from the prior quarter.

Reported value -23.7%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 1.57% This manager · Q1 2025
Shares 1,329,383 Quarter-end amount reported
Reported value $2,871,467 Fair value at quarter end
Consecutive quarters held 2 Through Q1 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q4 2025 Reduced 0 -979,956 (-100.0%) 0 $0 2026-02-17
Q3 2025 Added 979,956 +192,835 (24.5%) 0.63% $1,626,727 2025-11-14
Q2 2025 Reduced 787,121 -542,262 (-40.8%) 0.52% $928,803 2025-08-12
Q1 2025 Unchanged 1,329,383 0 (0.0%) 1.57% $2,871,467 2025-05-15
Q4 2024 New 1,329,383 +1,329,383 (0.0%) 1.68% $3,762,154 2025-02-14
Institutional context

Who else reported the position

26 managers reported CASI PHARMACEUTICALS HLDGS INC for Q1 2025.

Manager Activity Shares Change % of reported 13F Reported value Tenure
Foresite Capital Management VI LLC This report Unchanged 1,329,383 0 1.57% $2,871,467 2 qtrs
VR Adviser LLC Unchanged 987,259 0 0.18% $2,132,479 4 qtrs
Woodline Partners LP Added 164,365 +64,675 < 0.01% $355,028 3 qtrs
Wellington Shields Capital Management LLC Added 90,894 +5,059 0.04% $196,331 9 qtrs
ADAR1 Capital Management LLC Added 47,420 +1,100 0.02% $102,427 4 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 38,900 -500 < 0.01% $84,024 9 qtrs
Wellington Shields & Co LLC Unchanged 30,091 0 0.02% $64,997 9 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP New 21,143 +21,143 < 0.01% $45,669 1 qtr
GEODE CAPITAL MANAGEMENT LLC Unchanged 19,363 0 < 0.01% $41,824 9 qtrs
ROYAL BANK OF CANADA Added 9,700 +2,800 < 0.01% $21,000 3 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2025
Filed
May 15, 2025
Filing type
13F-HR
Position type
ORD SHS

Voting authority reported

Sole
1,329,383
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.